1. 1155PPhase I adoptive cellular therapy trial with ex-vivo stimulated autologous CD8+ T-cells against multiple targets (ACTolog® IMA101) in patients with relapsed and/or refractory solid cancers. (23rd October 2018) Authors: Tsimberidou, A-M; Ma, H; Stewart, C; Schoor, O; Maurer, D; Mendrzyk, R; Satelli, A; Fritsche, J; Stephens, G; Mohamed, A; Hwu, P; Yee, C; Reinhardt, C; Weinschenk, T; Gharpure, K; Stungis, A; Vining, D J; Singh, H; Walter, S; Andersson, B S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗